Current treatment of renal cell carcinoma.
De Mulder
P H M
PH
Department of Medical Oncology, University Medical Center Nijmegen, The Netherlands.
van Herpen
C M L
CM
Mulders
P A F
PA
D000970:Antineoplastic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000601:surgery*; D016207:Cytokines / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000601:surgery*
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D016207:Cytokines; D016898:Interferon-alpha; D007376:Interleukin-2